PIMREG and triple-A syndrome: CatS uses its activities in degrading ECM [27]–[29] and in processing and presenting antigens [32] to promote arterial wall elastinolysis and leukocyte recruitment [33] and angiogenesis [27], and to activate lymphocytes [32] – all which are important in AAA pathogenesis.